Cargando…

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Advanced glycation end products (AGEs) are compounds formed after the non-enzymatic addition of reducing sugars to lipids, proteins, and nucleic acids. They are associated with the development of various clinical complications observed in diabetes and cardiovascular diseases, such as retinopathy, ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koerich, Suélyn, Parreira, Gabriela Machado, de Almeida, Douglas Lamounier, Vieira, Rafael Pinto, de Oliveira, Antônio Carlos Pinheiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Neurology, Pharmacology, Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190138/ https://www.ncbi.nlm.nih.gov/pubmed/36154605 http://dx.doi.org/10.2174/1570159X20666220922153903

Ejemplares similares

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction
por: Fracasso, Bianca de Moraes, et al.
Publicado: (2019)

Berberine: A Promising Treatment for Neurodegenerative Diseases
por: Cheng, Ziqian, et al.
Publicado: (2022)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
por: Rahman, Md. Mominur, et al.
Publicado: (2023)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
por: Yaser, Al-Madhagi, et al.
Publicado: (2012)

The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice
por: Sambamurthy, Nisha, et al.
Publicado: (2015)

The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016)

Receptor for advanced glycation end-products (RAGE) mediates phagocytosis in nonprofessional phagocytes
por: Yang, Yan, et al.
Publicado: (2022)

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
por: Han, Dong, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
por: Almikhlafi, Mohannad A., et al.
Publicado: (2023)

RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin
por: Machado-Lima, Adriana, et al.
Publicado: (2020)

RAGE Inhibitors in Neurodegenerative Diseases
por: Reddy, V. Prakash, et al.
Publicado: (2023)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
por: Xue, Jing, et al.
Publicado: (2014)

Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus
por: Navel, Valentin, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
por: Yue, Qing, et al.
Publicado: (2022)

Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status
por: da Silva, Lívia Fontes, et al.
Publicado: (2019)

The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders
por: Correa, Bernardo H.M., et al.
Publicado: (2023)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
por: Zhu, Yumeng, et al.
Publicado: (2022)

Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
por: Boltze, Johannes, et al.
Publicado: (2020)

Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress
por: Wei, Qin, et al.
Publicado: (2013)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
por: Song, Juhyun, et al.
Publicado: (2014)

The Receptor for Advanced Glycation End Products (RAGE) Affects T Cell Differentiation in OVA Induced Asthma
por: Akirav, Eitan M., et al.
Publicado: (2014)

Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
por: Li, D.X., et al.
Publicado: (2014)

Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
por: Eichhorst, Alexandra, et al.
Publicado: (2019)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE)
por: Buyannemekh, Dolgorsuren, et al.
Publicado: (2017)

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors
por: Singh, Harbinder, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_geiia2jq4cn3dugmu939chfale